MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
What is the purpose of this trial?
We hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. the Artemis system will be used to collect one extra research biopsy from each ROI. An average of 2 ROIs are identified for each case; therefore an average of 2 additional biopsies would be required for this research study. These research biopsies will not affect prostate biopsies collected as part of standard clinical care.
- Ages18 years - 80 years
- GenderMale only
- Trial withYale University School of Medicine
- Start Date06/24/2013
- End Date10/31/2023
- Last Updated07/15/2021
- Study HIC#1304011902